New pill hopes to unleash immune system against tough cancers
NCT ID NCT05107674
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This early-phase study tests an experimental pill called NX-1607 in adults with advanced cancers that have not responded to standard treatments. The drug aims to boost the body's immune system to fight tumors. The main goals are to check safety and see if the drug can shrink or control cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrookes Cambridge University Hospital
RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Beatson West of Scotland Cancer Centre
RECRUITINGGlasgow, G12 0YN, United Kingdom
Contact Email: •••••@•••••
Contact
-
Churchill Hospital
COMPLETEDOxford, OX3 7LE, United Kingdom
-
City of Hope
COMPLETEDDuarte, California, 91010, United States
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
Contact Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
-
Northern Centre for Cancer Care
RECRUITINGNewcastle, NE7 7DN, United Kingdom
-
Royal Marsden Hospital NHS Foundation Trust
RECRUITINGSutton, Surrey, SM2 5PT, United Kingdom
-
Sarah Cannon Research Institute
RECRUITINGLondon, W1G 6AD, United Kingdom
Contact Email: •••••@•••••
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
Contact Email: •••••@•••••
Contact
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94158, United States
Contact Email: •••••@•••••
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Email: •••••@•••••
-
University of Colorado School of Medicine
RECRUITINGAurora, Colorado, 80045, United States
Contact Email: •••••@•••••
Contact
Contact
-
University of North Carolina
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Oklahoma
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact Email: •••••@•••••
Contact
-
University of Southern California
RECRUITINGLos Angeles, California, 90007, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.